These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1856146)

  • 21. Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children.
    Viganò A; Principi N; Brivio L; Tommasi P; Stasi P; Villa AD
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1499-503. PubMed ID: 1510446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative nephrotoxicity of hydroxygentamicin and other aminoglycosides in rats.
    Slighter RG; Montenaro MJ; Fabian RJ; Bhandari JC; Donikian MR; Drobeck HP
    Fundam Appl Toxicol; 1984 Aug; 4(4):558-67. PubMed ID: 6479501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective controlled evaluation of auditory function in neonates given netilmicin or amikacin.
    Finitzo-Hieber T; McCracken GH; Brown KC
    J Pediatr; 1985 Jan; 106(1):129-36. PubMed ID: 3880819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of netilmicin and gentamicin in the treatment of pelvic infections.
    Schnider G; Birken RA; Poindexter AN
    Obstet Gynecol; 1979 Nov; 54(5):554-7. PubMed ID: 503379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside dosing regimen and pharmacokinetic parameters in the guinea pig.
    Dionisotti S; Bamonte F; Leung P; Kramer WG; Ongini E
    Chemotherapy; 1990; 36(1):33-40. PubMed ID: 2307023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?
    Zhanel GG; Ariano RE
    Ren Fail; 1992; 14(1):1-9. PubMed ID: 1561384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of netilmicin and amikacin on urinary phospholipids excretion in humans.
    Ibrahim S; Van der Auwera P; Meunier F; Tulkens PM
    Arch Toxicol Suppl; 1989; 13():413-6. PubMed ID: 2774968
    [No Abstract]   [Full Text] [Related]  

  • 29. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring serum concentrations for once-daily netilmicin dosing regimens.
    Blaser J; König C; Simmen HP; Thurnheer U
    J Antimicrob Chemother; 1994 Feb; 33(2):341-8. PubMed ID: 8182017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycoside ototoxicity.
    Matz GJ
    Am J Otolaryngol; 1986; 7(2):117-9. PubMed ID: 3485932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
    Brion N; Barge J; Godefroy I; Dromer F; Dubois C; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):168-72. PubMed ID: 6712201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dosing aminoglycosides once a day].
    Blaser J
    Schweiz Med Wochenschr Suppl; 1996; 76():39S-48S. PubMed ID: 8677418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial.
    Tange RA; Dreschler WA; Prins JM; Büller HR; Kuijper EJ; Speelman P
    Clin Otolaryngol Allied Sci; 1995 Apr; 20(2):118-23. PubMed ID: 7634515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vivo bactericidal activity of an oxacillin-netilmicin combination against Staphylococcus aureus. Influence of the rhythm of netilmicin administration].
    Weber M; Voiriot P; Dopff C; Tronel H; Melet M; Dureux JB
    Pathol Biol (Paris); 1988 May; 36(5):389-93. PubMed ID: 3043334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections.
    de Vries PJ; Verkooyen RP; Leguit P; Verbrugh HA
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):161-8. PubMed ID: 2186909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of dosing regimen to aminoglycoside ototoxicity: evaluation of auditory damage in the guinea pig.
    Bamonte F; Dionisotti S; Gamba M; Ongini E; Arpini A; Melone G
    Chemotherapy; 1990; 36(1):41-50. PubMed ID: 2307024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of netilmicin administration once or three times daily in intensive care patients].
    Frass M; Traindl O; Podolsky A; Leithner C; Graninger W
    Wien Klin Wochenschr; 1991; 103(4):101-4. PubMed ID: 2042367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
    Marik PE; Havlik I; Monteagudo FS; Lipman J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():81-9. PubMed ID: 1856148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.
    Konrad F; Wagner R; Neumeister B; Rommel H; Georgieff M
    Intensive Care Med; 1993; 19(4):215-20. PubMed ID: 8366230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.